PAXIP1 and lung carcinoma: Specifically, Shaw et al. 31 identified oligodendroglial tumours that responded to chemotherapy had lower expression of SSBP2. Correspondingly, PAXIP1 is involved in the sensitization of lung cancer cells to the WEE1 inhibitor, AZD 1775, in combination with cisplatin29.